Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
07.05.24
/
50%
€4.98
Target price
07.05.25
€11.13
Performance (%)
13.48%
Price
15:58
€5.65
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL currently has a performance of 13.48%. This prediction currently runs until 07.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biocryst Pharmaceuticals | -5.013% | -5.013% |
iShares Core DAX® | -2.023% | -3.140% |
iShares Nasdaq 100 | 4.625% | 8.753% |
iShares Nikkei 225® | -2.088% | -0.980% |
iShares S&P 500 | 2.398% | 4.677% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
-5.83%
15:58
15:58
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.70
06.11.23
06.11.23
€11.17
06.11.24
06.11.24
-0.88%
15:58
15:58
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.47
03.08.23
03.08.23
€10.96
03.08.24
03.08.24
-12.62%
15:58
15:58
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€12.77
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24